Loss Of Lats12 Confers Resistance To Erlotinib Treatment In Cancer
Loss of LATS1/2 confers resistance to erlotinib treatment in cancer ...
Loss of LATS1/2 confers resistance to erlotinib treatment in cancer ...
Involvement of the AKT Pathway in Resistance to Erlotinib and ...
Suppression of c-MET overcomes erlotinib resistance in tongue cancer ...
(PDF) Erlotinib in the treatment of advanced non-small cell lung cancer ...
Effect of LMNA on cell proliferation and resistance to erlotinib in ...
Characterization of EGFR loss and erlotinib resistant phenotypes in ...
LMNA Reduced Acquired Resistance to Erlotinib in NSCLC by Reversing the ...
High cyclin D3 expression confers erlotinib resistance in aerodigestive ...
PIK3R2 depletion confers erlotinib resistance in ovarian cancer. (A ...
Advertisement Space (300x250)
Erlotinib Therapy in Non Small Cell Lung Cancer Patients - Survival of ...
Erlotinib treatment results in faster downregulation of L858R-YFP ...
(PDF) Targeting KCa3.1 channels to overcome erlotinib resistance in non ...
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung ...
Resistance to erlotinib upon EMT is independent of drug efflux, TGF-β ...
Erlotinib Mechanism of Action in Non-Small Cell Lung Cancer (NSCLC ...
Erlotinib Therapy in Non Small Cell Lung Cancer Patients - Survival of ...
Efficacy of aptamers and their combined treatment of erlotinib in ...
A novel combination treatment of antiADAM17 antibody and erlotinib to ...
Erlotinib Treatment in Colorectal Cancer Suppresses Autophagy Based on ...
Advertisement Space (336x280)
EnaV treatment overcomes resistance to EGFR inhibitors in vivo. (A ...
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib ...
Full article: Role of erlotinib in first-line and maintenance treatment ...
Full article: Role of erlotinib in first-line and maintenance treatment ...
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung ...
Erlotinib is a viable treatment for tumors with acquired resistance to ...
EP.12.22 Clinical Treatment Outcomes of Erlotinib in Metastatic Non ...
A combination of cancer inhibitors shows success in slowing tumor growth
A Decade of Advances in Treatment for Advanced Non–Small Cell Lung ...
Aldehyde dehydrogenase 1A1 confers erlotinib resistance via ...
Advertisement Space (336x280)
(PDF) Primary Erlotinib Resistance in a Patient with Non-Small Cell ...
Erlotinib treatment of NSCLC cell lines. (A) Effect of erlotinib on the ...
Interleukin-1 blockade overcomes erlotinib resistance in head and neck ...
Erlotinib Improves the Response of Glioblastoma Cells Resistant to ...
Combined treatment with metformin and erlotinib induces cell death in ...
Erlotinib treatment suppresses the cell viability and the levels of ...